Skip to main content
Premium Trial:

Request an Annual Quote

US Genomics Raises $17M in Private Placement

NEW YORK, April 4 – US Genomics of Woburn, Mass., said Wednesday it has raised $17 million in private financing, which will be used to develop the company’s DNA analysis technology.

HealthCare Ventures and existing investors, including CB Health Ventures and Still River Fund, contributed to the financing round. Augustine Lawlor, general partner at HealthCare Ventures, also joined US Genomics’ board of directors.

"US Genomics has created a powerful, fundamental new technology that carries the potential of enabling commercial applications of genetics analysis across a broad range of industries," Lawlor said in a statement.

US Genomics said its technology, which is designed to generate haplotype data, allows researchers to read long stretches of genetic sequence data in a direct, linear fashion. The company plans to eventually use the technology to read whole genomes and to apply it to drug discovery and diagnostics.

A company spokesman was not immediately available to explain how the technology works.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.